Chiesi Global Rare Diseases Showcases Ongoing Commitment to
• Results presented from a large, pooled database from three Phase 3 clinical trials evaluating MYCAPSSA (octreotide) for the treatment ...
Read more• Results presented from a large, pooled database from three Phase 3 clinical trials evaluating MYCAPSSA (octreotide) for the treatment ...
Read moreVALENCIA, Spain, June 02, 2024 (GLOBE NEWSWIRE) -- Allergic diseases cost between 1,823€ and 6,656€ per patient per year if ...
Read moreTo create awareness and enable knowledge-sharing around Venous diseases, in order to drive better patient care BD (Becton, Dickinson, ...
Read moreFILSUVEZ topical gel is indicated for the treatment of partial thickness wounds in patients 6 months and older with Junctional ...
Read moreTakeda Emphasizes the Need for Cross-sectoral Alliances to Address the Burden of Vector-Borne Infectious Diseases
Read moreSHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a ...
Read moreAfter Parliament passed the Prohibition of Electronic Cigarettes Bill, 2019, doctors have raised concerns about people becoming vulnerable to ...
Read moreIndia is currently faced with the triple burden of communicable, non-communicable diseases (NCDs) and injuries. According to the World ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.